Browse > Article
http://dx.doi.org/10.3345/kjp.2009.52.3.364

Clinical factors causing hyponatremia in patients with mucocutaneous lymph node syndrome  

Kim, Soo Yeon (Department of Pediatrics, Eulji University School of Medicine)
Kim, Hyun Jung (Department of Pediatrics, Eulji University School of Medicine)
Choi, Jun Seok (Department of Pediatrics, Eulji University School of Medicine)
Huh, Jae Kyung (Department of Pediatrics, Eulji University School of Medicine)
Publication Information
Clinical and Experimental Pediatrics / v.52, no.3, 2009 , pp. 364-369 More about this Journal
Abstract
Purpose : Clinical and laboratory findings predict a severe outcome for mucocutaneous lymph node syndrome. This study aimed to define the clinical characteristics of Kawasaki disease (KD) patients with hyponatremia and to determine the factors associated with its development. Methods : Retrospective studies were performed on 114 KD patients who received an initial high-dose intravenous immunoglobulin (IVIG, single 2 g/kg/dose) within 10 days of fever onset from January 2006 to February 2008. These patients were divided into 2 groups. Group 1 consisted of 30 (26.3%) patients with hyponatremia, and group 2 consisted of 84 (73.6%) patients without hyponatremia. Clinical manifestations, laboratory results, and echocardiographic findings were compared between the groups. Results : Group 1 patients were more likely to have a coronary artery lesion (53.3% versus 20.2%, P=0.005) and suffered from diarrhea (41.3% versus 14.1%, P=0.007). There was a higher incidence of cardiovascular involvement in group 1 patients, including coronary dilatation (46.6%), valvular regurgitation (13.3%), pericardial effusion (6.7%) and medium-sized aneurysm (6.7%). There were no coronary aneurysms in group 2 patients. Serum C-reactive protein (CRP) was significantly higher in patients with hyponatremia ($12.2{\pm}7.79$ mg/dL versus $7.3{\pm}4.7$ mg/dL, P=0.003) and IVIG-resistant patients were more common in group 1 (13.3% versus 3.6%). Conclusion : These results indicate that hyponatremia in KD occurs in patients exhibiting severe inflammation and was significantly associated with the development of coronary disease. Further studies will be necessary to confirm the pathogenic mechanisms of hyponatremia in KD patients.
Keywords
Mucocutaneous lymph node syndrome; Hyponatremia; Coronary disease;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Asai T. Evaluation method for the degree of seriousness in Kawasaki disease. Acta Paediatr Jpn 1983;25:170-5   DOI
2 Leung DYM, Meissner HC, Fulton DR, Quimby F, Schlievert PM. Superantigens in Kawasaki syndrome. Clin Immunol Immunopathol 1995;77:119-26   DOI   ScienceOn
3 Bonany PJ, Bilkis MD, Gallo G, Lago N, Dennehy MV, Sosa del Valle JM, et al. Acute renal failure in typical Kawasaki disease. Pediatr Nephrol 2002;17:329-31   DOI   ScienceOn
4 Nakamura Y, Yashiro M, Uehara R, Watanabe M, Tajimi M, Oki I, et al. Use of laboratory data to identify risk factors of giant coronary aneurysms due to Kawasaki disease. Pediatr Int 2004;46:33-8   DOI   ScienceOn
5 Jia EZ, Yang ZJ, Zhu TB, Wang LS, Chen B, Cao KJ, et al. Serum sodium concentration is significantly associated with the angiographic characteristics of coronary atherosclerosis. Acta Pharmacol Sin 2007;28:1136-42   DOI   ScienceOn
6 De Luca L, Klein L, Udelson JE, Orlandi C, Sardella G, Fedele F, et al. Hyponatremia in patients with heart failure. Am J Cardiol 2005;96:19-23
7 Eisenhut M. Changes in renal sodium transport during a systemic inflammatory response. Pediatr Nephrol 2006;21: 1487-8   DOI   ScienceOn
8 Ohno T, Yuge T, Kariyazono H, Igarashi H, Jono K, Kinugawa N, et al. Serum hepatocyte growth factor combined with vascular endothelial growth factor as a predictive indicator for the occurrence of coronary artery lesions in Kawasaki disease. Eur J Pediatr 2002;161:105-11   DOI   ScienceOn
9 Kobayashi T, Inoue Y, Takeuchi K, Okada Y, Tamura K, Tomomasa T, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006;113:2606-12   DOI   ScienceOn
10 Ohta K, Seno A, Shintan N, Kato E, Yachie A, Seki H, et al. Increased levels of urinary interleukin-6 in Kawasaki disease. Eur J Pediatr 1993;152:647-9   DOI   ScienceOn
11 Nakabayashi Y, Shimizu T. Hyponatremia in Kawasaki disease. Nippon Shoni Jinzobyo Gakkai Zasshi 2002;15:83-7   DOI
12 Muta H, Ishii M, Egami K, Hayasaka S, Nakamura Y, Yanagawa H, et al. Serum sodium levels in patients with Kawasaki disease. Pediatr Cardiol 2005;26:404-7   DOI   ScienceOn
13 Dajani AS, Taubert KA, Takahashi M, Bierman FZ, Freed MD, Ferrieri P, et al. Guidelines for long-term management of patients with Kawasaki disease. Report from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation 1994;89:916-22   PUBMED   ScienceOn
14 Kato H, Sugimura T, Akagi T, Sato N, Hashino K, Maeno Y, et al. Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. Circulation 1996;94:1379-85   PUBMED   ScienceOn
15 Han RK, Silverman ED, Newman A, McCrindle BW. Management and outcome of persistent or recurrent fever after initial intravenous gamma globulin therapy in acute Kawasaki disease. Arch Pediatr Adolesc Med 2000;154:694-9   PUBMED
16 Koyanagi H, Nakamura Y, Yanagawa H. Lower level of serum potassium and higher level of C-reactive protein as an independent risk factor for giant aneurysms in Kawasaki disease. Acta Paediatr 1998;87:32-6   DOI   ScienceOn
17 Durongpisitkul K, Soongswang J, Laohaprasitiporn D, Nana A, Prachuabmoh C, Kangkagate C. Immunoglobulin failure and retreatment in Kawasaki disease. Pediatr Cardiol 2003; 24:145-8   DOI   ScienceOn
18 Watanabe T, Abe Y, Sato S, Uehara Y, Ikeno K, Abe T. Hyponatremia in Kawasaki disease. Pediatr Nephrol 2006; 21:778-81   DOI   ScienceOn
19 Koren G, Lavi S, Rose V, Rowe R. Kawasaki disease: review of risk factors for coronary aneurysms. J Pediatr 1986; 108:388-92   DOI
20 Takahashi M. Kawasaki syndrome (mucocutaneous lymph node syndrome). In: Allen HD, Gutgesell HD, Clark EB, Driscoll DJ, editors. Moss and Adams' heart disease in infants, children, and adolescents including the fetus and young adults. 6th ed. Philadelpia : Lippinocott Williams & Wilkins Co, 2001;1216-25
21 Laxer RM, Petty RE. Hyponatremia in Kawasaki disease. Pediatrics 1982;4:655   DOI
22 Burns JC, Capparelli EV, Brown JA, Newburger JW, Glode MP. Intravenous gamma-globulin treatment and retreatment in Kawasaki disease. US/Canadian Kawasaki Syndrome Study Group. Pediatr Infect Dis J 1998;17:1144-8   DOI   ScienceOn
23 Harada K, Yamaguchi H, Kato H. Indication for intravenous gamma globulin treatment for Kawasaki disease. In : Takahashi M, Taubert K, editors. Proceedings of the Fourth International Symposium on Kawasaki disease. American Heart Association, Dallas, 1993:459-62
24 Maeno N, Takei S, Masuda K, Akaike H, Matsuo K, Kitajima I, et al. Increased serum levels of vascular endothelial growth factor in Kawasaki disease. Pediatr Res 1998;44:596- 9   DOI   ScienceOn
25 Research Committee on Kawasaki disease. Report of subcommittee on standardization of diagnostic criteria and reporting of coronary artery lesions in Kawasaki disease. Ministry of Health and Welfare, Tokyo, 1984
26 Leung DYM, Chu ET, Wood N, Grady S, Meade R, Geha RS. Immno regulartory T cell abnormalities in mucocutaneous lymph node syndrome. J Immunol 1983;130:2002-4
27 Mine K, Takaya J, Hasui M, Ikemoto Y, Teraguchi M, Kobayashi Y. A case of Kawasaki disease associated with syndrome of inappropriate secretion of antidiuretic hormone. Acta Paediatr 2004;93:1547-9   DOI   ScienceOn
28 Dajani AS, Taubert KA, Gerber MA, Shulman ST, Ferrieri P, Freed M, et al. Diagnosis and therapy of Kawasaki disease in children. Circulation 1993;87:1776-80   PUBMED   ScienceOn
29 Suzuki H, Takeuchi T, Minami T, Shibuta S, Uemura S, Yoshikawa N. Water retention in the acute phase of Kawasaki disease: relationship between oedema and the development of coronary artery lesions. Eur J Pediatr 2003;162:856-9   DOI   ScienceOn
30 Rhodes J, King ME, Aretz HT. An 11-year-old girl with fever, hypotension and azotemia. N Engl J Med 1998;339: 1619-26   DOI   ScienceOn
31 Jibiki T, Terai M, Kohno Y. High concentrations of interleukin-8 and monocyte chemoattractant protein-1 in urine of patients with acute Kawasaki disease. Eur J Pediatr 2004; 163:749-50   DOI   ScienceOn
32 Fujiwara T, Fujiwara H, Hamashima Y. Frequency and size of coronary arterial aneurysm at necropsy in Kawasaki disease. Am J Cardiol 1987;59:808-11   DOI   ScienceOn
33 Beiser AS, Takahashi M, Baker AL, Sundel RP, Newburger JW. A predictive instrument for coronary artery aneurysms in Kawasaki disease. US Multicenter Kawasaki Disease Study Group. Am J Cardiol 1998;81:1116-20   DOI   ScienceOn
34 Harada K. Intravenous gamma-globulin treatment in Kawasaki disease. Acta Paediatr Jpn 1983;25:170-5   DOI
35 Ferriero DM, Wolfsdorf JI. Hemolytic uremic syndrome associated with Kawasaki disease. Pediatrics 1981;68:405-6   PUBMED
36 Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, et al. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. J Pediatr 2006; 149:237-40   DOI   ScienceOn